Skip to main content
. 2023 Aug 14;29(9):2366–2374. doi: 10.1038/s41591-023-02507-0

Table 2.

Incidence of adverse events during the trial

Episodes Participants
n n (%)
AE information
 Total AEs 51 12 (100)
 Treatment-related AEs 21 9 (75)
 Total SAEs 1 1 (8)
 Treatment-related SAEs 0 0 (0)
 AEs leading to withdrawal 0 0 (0)
 Deaths 0 0 (0)
AEs by study phase
 Surgical 10 7 (58)
 Rehab-only 4 4 (33)
 Programming 12 7 (58)
 DBS + rehab 7 5 (42)
 Rehab carryover 5 5 (42)
 Explant 4 3 (25)
 Long-term follow-up 9 7 (58)

AE, adverse event; SAE, serious adverse event; rehab, rehabilitation.